Shuttle Pharmaceuticals Holdings (SHPH) Liabilities and Shareholders Equity (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Liabilities and Shareholders Equity history runs 6 years deep, the most recent figure standing at $11.8 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 122.39% year-over-year to $11.8 million; the TTM figure through Mar 2026 stood at $31.3 million (up 177.21% YoY), while the FY2025 annual figure was $10.5 million, up 317.99% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $11.8 million, up from $10.5 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $11.8 million in Q1 2026, with the low at $673568.0 in Q3 2024.
• The 5-year median for Liabilities and Shareholders Equity is $6.0 million (2023), against an average of $6.5 million.
• The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity soared 1227.96% in 2022, then plunged 90.87% in 2024.
• Shuttle Pharmaceuticals Holdings' Liabilities and Shareholders Equity stood at $8.7 million in 2022, then slumped by 31.22% to $6.0 million in 2023, then plunged by 57.89% to $2.5 million in 2024, then soared by 317.99% to $10.5 million in 2025, then rose by 12.73% to $11.8 million in 2026.
• Business Quant data shows SHPH's Liabilities and Shareholders Equity at $11.8 million in Q1 2026, $10.5 million in Q4 2025, and $3.5 million in Q3 2025.